Christian Riedel
Hello, everyone. Welcome to this PTX Investor Briefing. Whereas individuals settle in, I will simply present the disclaimer for the session rapidly.
The shows that we host are appropriate for self-directed traders who’ve the expertise and capabilities to make their very own knowledgeable selections. Any info contained in right this moment’s presentation is normal nature doesn’t take into account your private circumstances to think about for your self and is suitable for you. The data we’re providing you with is for instructional functions solely. Previous efficiency not a dependable indicator of future efficiency.
Nice. With that, let’s kick off the session. I am Christian Riedel, Government Director at Attain. I will be internet hosting the session right this moment. Many would possibly know me from the latest capital elevate the place James and I did simply fairly a number of of those webcasts to each shareholders and potential new traders. James is right here with me, James McDonnell, CEO of Prescient. And right this moment’s replace is off the again of their latest 4C announcement, which included an replace on the Section IIa examine for most cancers therapy of PTX-100 with 7 medical websites now open in Australia and the U.S.
How we’ll run the session is I will first ask James a number of questions concerning the latest information, latest releases, after which I will let him run by way of the deck. It will likely be, I believe, a mix of, the traditional deck and in addition the AGM presentation and reflecting a few of these new releases. After which we’ll observe up with some Q&A to catch something we’ve not coated and in addition open the ground to the viewers right here to get an replace. We count on the session to
